1 / 7

Global Antibodies Market Trends, Regulations And Competitive Landscape Outlook to 2026

Antibodies are becoming popular in the clinical practice for their use in the treatment of variety of clinical conditions such as cardiovascular and infectious diseases, autoimmune and CNS disorders, cancer and inflammation. Owing to their stable nature and high affinity for variety of biomolecules, antibodies are considered as best targeting and diagnostic reagents. In order to show their effects antibodies need to interact with elements of immune system and initiate the reaction cascade.

shekharm1
Download Presentation

Global Antibodies Market Trends, Regulations And Competitive Landscape Outlook to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Antibodies Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016 – 2026 www.futuremarketinsights.com Future Market Insights sales@futuremarketinsights.com

  2. Report Description Report Description Antibodies are becoming popular in the clinical practice for their use in the treatment of variety of clinical conditions such as cardiovascular and infectious diseases, autoimmune and CNS disorders, cancer and inflammation. Owing to their stable nature and high affinity for variety of biomolecules, antibodies are considered as best targeting and diagnostic reagents. In order to show their effects antibodies need to interact with elements of immune system and initiate the reaction cascade. Antibody engineering technique enabled the production of humanized antibodies which are more efficient and less immunogenic than chimeric and murine antibodies. More than 22 antibodies are currently available in the market for the treatment of cancer and immunological disorders. Novel technique of antibody-drug complex is proving more beneficial due to its selectivity towards the diseased cells. Some of the examples of therapeutic antibodies available in the market are ADL518 (rheumatoid arthritis), Aducanumab (Alzheimer’s disease), Alirocumab (hypercholesterolemia), Daclizumab (transplant rejection), Omalizumab (allergic asthma), Rituximab (cancer) etc. Antibodies Market: Drivers and Restraints Monoclonal antibodies are gaining more acceptance as a new therapeutic molecule due to high efficacy and lesser side effects. Advancements in technology and development of new molecules are believed to play a crucial role in the growth of global antibodies market during the forecast period. But the limited production capacity and restricted clinical applications of antibodies will always remain the greatest restraints for the global antibodies market.

  3. Report Description Report Description Antibodies Market: Segmentation The global antibodies market has been classified on the basis of product type, type of disease, end user and geography. Based on product type, the global antibodies market is divided into following: • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Antibody-based vaccines Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb- 1330 Based on the disease type, the global antibodies market is divided into following: • Cardiovascular diseases • CNS disorders • Cancer • Autoimmune disorders • Others Based on the end user type, the global antibodies market is divided into following: • Hospitals

  4. Report Description Report Description • • Diagnostic centers Research institutes Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1330 Antibodies Market: Overview Antibodies are majorly used in the treatment of cancers and immunological disorders as they are proving beneficial over the other chemotherapeutic agents. Monoclonal antibodies market segment holds the largest share in the market in 2014. Launching of novel antibody-drug complexes in coming future is expected to boost up the market volume. More than 30 antibody molecules and combination treatments are in the clinical trial pipeline. Some of them are expected to be launched in the global antibodies market in the forecast period such as Bortezomib, Eculizumab, VRC 606 to name a few. Antibodies for the treatment of infectious diseases has a least importance due to low penetration of large molecules inside the cells. Antibodies Market: Regional Overview Region wise, the global antibodies market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America holds the largest share in the global antibodies market followed by Europe and Asia Pacific. Asia Pacific antibodies market is expected to grow at faster rate among other regions owing to the high patient population pool available and the increasing investments and

  5. Report Description Report Description collaborations in the biotechnology industry over the forecast period from 2016 to 2026. Increasing demands for the monoclonal antibodies in countries such as China and India to treat the infectious diseases is expected to increase the production of antibodies. Full Report Analysis@ http://www.futuremarketinsights.com/reports/antibodies-market Antibodies Market: Key Players Some of the key players in global antibodies market are Sigma-Aldrich Corporation, Roche Ltd., Abcam plc, Sanofi S.A., Rockland Immunochemicals, AbbVie Inc., Amgen Inc., Thermo Fisher Scientific Inc., Novartis AG, Biogen-Idec Limited, MedImmune, GE Healthcare, Abnova Corporation and others.

  6. Future Market Insights (FMI) is apremier provider of syndicated research reports, custom research reports, andconsulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technologyinputs,valuablegrowthinsights,aerialviewofthecompetitiveframework,andfuturemarkettrends. Weprovideresearchservicesat aglobalas wellas regionallevel;keyregionsincludeGCC, ASEAN,andBRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for ourclient. Research Capabilities  Customized Research  Syndicated Research  Investment Research  Social Media Research  Healthcare, Pharmaceuticals & Medical Devices Sector Coverage  Automotive and Transportation  Electronics, Semiconductor, and ICT  Retail and Consumer Products  Industrial Automation and Equipment  Chemicals & Materials  Food and Beverages  Services and Utilities  Energy, Mining, Oil, and Gas Subscription Information Customized Research Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager -Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research

  7. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For other queries contact: Mr. Sudip Saha Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States 3531 |

More Related